文献速递产科母胎医学

体外受精妊娠常规胎儿超声心动图筛查的价值

Utility of routine screening fetal echocardiogram in pregnancies conceived by in vitro fertilization.
PubMed 文献 · Fertil Steril · 2021-06-29

本研究比较2012至2018年胎儿超声心动图数据库与州出生缺陷登记数据,分析IVF妊娠中先天性心脏病的发生率与临床意义。在2040例无其他危险因素的IVF妊娠中,先心病风险比1.4(95%CI 0.9-2.1),多数诊断的室间隔缺损无临床意义,每510次超声心动图才发现1例有临床意义的先心病。结论认为无其他危险因素时常规筛查价值有限,不建议对所有IVF妊娠常规推荐。

要点

  • 无其他危险因素的IVF妊娠先心病风险与人群基线无显著差异。
  • IVF组诊断的先心病多为无临床意义的室间隔缺损。
  • 每510次胎儿超声心动图仅发现1例有临床意义的先心病。

核心结论

  • 无其他危险因素的IVF妊娠先心病发生率与基线人群无显著差异。
  • 该组经胎儿超声心动图诊断的先心病多数无临床意义。
  • 对所有IVF妊娠常规筛查胎儿超声心动图价值有限,无其他危险因素时不必推荐。

研究设计与样本

  • 队列研究,比较2012至2018年前瞻性维护的胎儿超声心动图数据库与康涅狄格州出生缺陷登记及全州医院出院汇总数据。
  • 共分析181749例活产和9252例胎儿超声心动图。
  • 排除有先心病患儿、先心病家族史、药物暴露、糖尿病、前次妊娠异常、前次超声发现心脏或其他异常、单绒毛膜双胎的病例。

主要发现

  • IVF妊娠中行胎儿超声心动图2230例,其中2040例无其他已知先心病危险因素。
  • 胎儿超声心动图时平均孕周22.2±1.4周。
  • IVF组先心病风险比与全州人群率比较为1.4(95%CI 0.9-2.1)。
  • 诊断先心病26例,其中21例为无临床意义的室间隔缺损,1例胎儿超声提示肺动脉狭窄但出生时不存在。
  • 4例有临床意义,表明IVF组每510次胎儿超声心动图发现1例有临床意义的先心病。

关键数值与推荐

  • 临床显著疾病预设定义为需要任何药物或手术干预或继续儿科心脏科随访的疾病。
  • IVF组与全州人群比较先心病OR为1.4(95%CI 0.9-2.1)。
  • 无其他危险因素的IVF妊娠2040例中诊断先心病26例。

临床怎么用

  • 对无其他危险因素的IVF妊娠,不必常规推荐胎儿超声心动图筛查。
  • 应结合其他危险因素决定是否行胎儿超声心动图。
  • 咨询时可告知IVF妊娠先心病风险与基线人群无显著差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To study the incidence and clinical significance of congenital heart defects (CHDs) detected by fetal echocardiography in pregnancies conceived by in vitro fertilization (IVF). DESIGN: Cohort study comparing a prospectively maintained database of all fetal echocardiograms from 2012 to 2018 and pooled data from the Connecticut Birth Defects Registry and statewide hospital discharge data. SETTING: Large tertiary care center. PATIENT(S): A total of 181,749 live births and 9,252 fetal echocardiograms were analyzed. Fetal echocardiograms in patients with a previous child with a CHD, a family history of CHD, medication exposure, diabetes, anomaly in previous pregnancy, cardiac or other abnormality noted on previous ultrasound, or monochorionic twins were excluded from the final analysis. INTERVENTION(S): Treatment with IVF. MAIN OUTCOME MEASURE(S): Incidence of CHD and odds ratios with 95% confidence intervals (CIs). Infant outcomes for cases of CHD were evaluated for clinically significant disease, defined a priori as disease requiring any medical or surgical intervention or continued follow-up with pediatric cardiology. RESULT(S): Fetal echocardiography was performed in 2,230 IVF pregnancies, of which 2,040 were without other known risk factors for CHD. The mean gestational age at the time of fetal echocardiography was 22.2 ± 1.4 weeks. The odds ratio for CHD in the IVF group compared with statewide population rates was 1.4 (95% CI 0.9-2.1). CHD was diagnosed in 26 fetuses, of which 21 were clinically insignificant ventricular septal defects. One fetal echocardiogram was concerning for pulmonary stenosis that was not present at birth. Four defects were clinically significant, indicating that 510 fetal echocardiograms were performed for every diagnosis of one clinically significant CHD in the IVF group. CONCLUSION(S): The incidence of CHD in IVF pregnancies without other risk factors is not significantly different from baseline population rates, and most CHDs diagnosed by fetal echocardiography in this group are clinically insignificant. Routine screening with fetal echocardiography in all IVF pregnancies provides limited utility beyond routine prenatal care and need not be recommended without the presence of other risk factors.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Bjorkman KR, Bjorkman SH, Ferdman DJ, et al. Utility of routine screening fetal echocardiogram in pregnancies conceived by in vitro fertilization. Fertil Steril. 2021. PMID: 34210397. doi:10.1016/j.fertnstert.2021.04.035

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。